25 extractive question-and-answer pairs built from Alcohol Use Disorders, published by icmr.gov.in. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. 18 of the 25 pairs (72.0%) are explanatory questions and 7 restate a figure. 96.00% of rows pass the corpus quality gate.
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/alcohol-use-disorders-question-and-answer-dataset/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("alcohol-use-disorders-question-and-answer-dataset")
df.head()Sign in with Google to download.
Usable for analysis, but expect some cleaning before you rely on it.
Consensus Document on Management of Pancreatic Cancer - Question and Answer Dataset
Economy · 268 rows
ICMR Standard Treatment Workflow for Cataract - Question and Answer Dataset
Economy · 27 rows
Neurology Questions from P a R T N E R S - Question and Answer Dataset
Economy · 107 rows
Beginner's Guide for Systematic Reviews - Question and Answer Dataset
Economy · 407 rows
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1,013 rows
Higher Education in India - Question and Answer Dataset
Economy · 1,594 rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1,101 rows
First 10 of 25 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|
| What is the definition of binge drinking for men? | 5 drinks over 2 hours | • Age at initiation, quantity, frequency and progression (daily use and/or morning drinking) • Time of last alcohol use and amount • Binge drinking ( men: 5 drinks over 2 hours; women: 4 drinks over 2 hours) • Withdrawal state: insomnia, restlessness, anxiety, tremors. | 155 | definition | 1.000 | • Age at initiation, quantity, frequency and progression (daily use and/or morning drinking) • Time of last alcohol use and amount • Binge drinking ( men: 5 drinks over 2 hours; women: 4 drinks over 2 hours) • Withdrawal state: insomnia, restlessness, anxiety, tremors. | 1 | page=1,block=3 | 0.700 | valid |
| What is the definition of binge drinking for women? | 4 drinks over 2 hours | • Age at initiation, quantity, frequency and progression (daily use and/or morning drinking) • Time of last alcohol use and amount • Binge drinking ( men: 5 drinks over 2 hours; women: 4 drinks over 2 hours) • Withdrawal state: insomnia, restlessness, anxiety, tremors. | 185 | definition | 1.000 | • Age at initiation, quantity, frequency and progression (daily use and/or morning drinking) • Time of last alcohol use and amount • Binge drinking ( men: 5 drinks over 2 hours; women: 4 drinks over 2 hours) • Withdrawal state: insomnia, restlessness, anxiety, tremors. | 1 | page=1,block=3 | 0.700 | valid |
| What is tolerance in the context of alcohol use? | increased doses of alcohol taken to achieve effects produced by earlier intake | Use of alcohol (or benzodiazepines) to relieve or avoid withdrawal symptoms. • Tolerance: increased doses of alcohol taken to achieve effects produced by earlier intake • Craving • Difficulty in controlling duration of drinking or amount of use • Preoccupation with alcohol use with neglect of alternative pleasures or interests • Increased time spent to obtain/ take alcohol/ recover from its effects • Continued use despite patient being aware of evidence of harmful consequences that have occurred • Abstinence and treatment attempts in past and reasons for relapse • Co-morbid medical illness or psychiatric illness and their treatment • Complications: • Physical- gastritis, peripheral neuropathy, hepatic dysfunction, accidents/injuries • Psychosocial - loss of work, fights at home, financial, legal problems NEUROLOGICAL SIGNS • Cerebellar signs • Peripheral neuropathy • Confusion CT head (in case of seizure/ delirium tremens) | 90 | definition | 1.000 | • Tolerance: increased doses of alcohol taken to achieve effects produced by earlier intake • Craving • Difficulty in controlling duration of drinking or amount of use • Preoccupation with alcohol use with neglect of alternative pleasures or interests • Increased time spent to obtain/ take alcohol/ recover from its effects • Continued use despite patient being aware of evidence of harmful consequences that have occurred • Abstinence and treatment attempts in past and reasons for relapse • Co-morbid medical illness or psychiatric illness and their treatment • Complications: • Physical- | ||||
| What is the term for needing increased doses of alcohol to achieve the same effects? | Tolerance: increased doses of alcohol taken to achieve effects produced by earlier intake | Use of alcohol (or benzodiazepines) to relieve or avoid withdrawal symptoms. • Tolerance: increased doses of alcohol taken to achieve effects produced by earlier intake • Craving • Difficulty in controlling duration of drinking or amount of use • Preoccupation with alcohol use with neglect of alternative pleasures or interests • Increased time spent to obtain/ take alcohol/ recover from its effects • Continued use despite patient being aware of evidence of harmful consequences that have occurred • Abstinence and treatment attempts in past and reasons for relapse • Co-morbid medical illness or psychiatric illness and their treatment • Complications: • Physical- gastritis, peripheral neuropathy, hepatic dysfunction, accidents/injuries • Psychosocial - loss of work, fights at home, financial, legal problems NEUROLOGICAL SIGNS • Cerebellar signs • Peripheral neuropathy • Confusion CT head (in case of seizure/ delirium tremens) | 79 | definition | 1.000 | • Tolerance: increased doses of alcohol taken to achieve effects produced by earlier intake • Craving • Difficulty in controlling duration of drinking or amount of use • Preoccupation with alcohol use with neglect of alternative pleasures or interests • Increased time spent to obtain/ take alcohol/ recover from its effects • Continued use despite patient being aware of evidence of harmful consequences that have occurred • Abstinence and treatment attempts in past and reasons for relapse • Co-morbid medical illness or psychiatric illness and their treatment • Complications: • Physical- | ||||
| What is the equivalent dose of Lorazepam to 5 mg of Diazepam for patients with significant liver dysfunction? | 2 mg Lorazepam equal to 5 mg Diazepam | • Tab Diazepam (20-40mg/day in divided doses) based on severity of withdrawals. • Monitor and titrate dose. • If patient comfortable, reduce dose of medication by 10% to 20% per day, taper within 7 to 10 days • Thiamine 100 mg OD • Significant liver dysfunction: Lorazepam (2 mg Lorazepam equal to 5 mg Diazepam) CBC Liver function test Blood sugar Electrolytes | 274 | comparison | 0.920 | • If patient comfortable, reduce dose of medication by 10% to 20% per day, taper within 7 to 10 days • Thiamine 100 mg OD • Significant liver dysfunction: Lorazepam (2 mg Lorazepam equal to 5 mg Diazepam) CBC Liver function test Blood sugar Electrolytes | 1 | page=1,block=30 | 0.700 | valid |
| What is the Lorazepam dose equivalent to 5 mg of Diazepam? | 2 mg Lorazepam | • Tab Diazepam (20-40mg/day in divided doses) based on severity of withdrawals. • Monitor and titrate dose. • If patient comfortable, reduce dose of medication by 10% to 20% per day, taper within 7 to 10 days • Thiamine 100 mg OD • Significant liver dysfunction: Lorazepam (2 mg Lorazepam equal to 5 mg Diazepam) CBC Liver function test Blood sugar Electrolytes | 274 | comparison | 0.840 | • If patient comfortable, reduce dose of medication by 10% to 20% per day, taper within 7 to 10 days • Thiamine 100 mg OD • Significant liver dysfunction: Lorazepam (2 mg Lorazepam equal to 5 mg Diazepam) CBC Liver function test Blood sugar Electrolytes | 1 | page=1,block=30 | 0.700 | valid |
| What potential causes of delirium should be excluded in tertiary care? | head injury, hepatic encephalopathy, Wernicke’s encephalopathy | Higher dosage may be required. • Closer monitoring and nursing care • Treatment of additional psychiatric disorder or substance use disorder TERTIARY CARE • Treatment of delirium tremens • R/ o head injury, hepatic encephalopathy, Wernicke’s encephalopathy • R/ o other causes of delirium • Manage on similar lines as withdrawal seizures • Management in ICU setting when indicated • Consult with other medical specialists (like gastroenterology or medicine for hematemesis). • Management for suicidality or violence when emergent threat PRIMARY CARE • Alcohol Hazardous/ Harmful users - Brief Intervention* to reduce/stop consumption • Alcohol Dependent users – Advice to stop use and motivate for treatment using Brief intervention* | 194 | list | 0.820 | • Closer monitoring and nursing care • Treatment of additional psychiatric disorder or substance use disorder TERTIARY CARE • Treatment of delirium tremens • R/ o head injury, hepatic encephalopathy, Wernicke’s encephalopathy • R/ o other causes of delirium • Manage on similar lines as withdrawal seizures • Management in ICU setting when indicated • Consult with other medical specialists (like gastroenterology or medicine for hematemesis). | ||||
| What is a potential cause of delirium that should be ruled out in tertiary care? | head injury, hepatic encephalopathy, Wernicke’s encephalopathy | Higher dosage may be required. • Closer monitoring and nursing care • Treatment of additional psychiatric disorder or substance use disorder TERTIARY CARE • Treatment of delirium tremens • R/ o head injury, hepatic encephalopathy, Wernicke’s encephalopathy • R/ o other causes of delirium • Manage on similar lines as withdrawal seizures • Management in ICU setting when indicated • Consult with other medical specialists (like gastroenterology or medicine for hematemesis). • Management for suicidality or violence when emergent threat PRIMARY CARE • Alcohol Hazardous/ Harmful users - Brief Intervention* to reduce/stop consumption • Alcohol Dependent users – Advice to stop use and motivate for treatment using Brief intervention* | 194 | list | 0.820 | • Closer monitoring and nursing care • Treatment of additional psychiatric disorder or substance use disorder TERTIARY CARE • Treatment of delirium tremens • R/ o head injury, hepatic encephalopathy, Wernicke’s encephalopathy • R/ o other causes of delirium • Manage on similar lines as withdrawal seizures • Management in ICU setting when indicated • Consult with other medical specialists (like gastroenterology or medicine for hematemesis). | ||||
| What conditions should be ruled out during tertiary care for delirium management? | head injury, hepatic encephalopathy, Wernicke’s encephalopathy | Higher dosage may be required. • Closer monitoring and nursing care • Treatment of additional psychiatric disorder or substance use disorder TERTIARY CARE • Treatment of delirium tremens • R/ o head injury, hepatic encephalopathy, Wernicke’s encephalopathy • R/ o other causes of delirium • Manage on similar lines as withdrawal seizures • Management in ICU setting when indicated • Consult with other medical specialists (like gastroenterology or medicine for hematemesis). • Management for suicidality or violence when emergent threat PRIMARY CARE • Alcohol Hazardous/ Harmful users - Brief Intervention* to reduce/stop consumption • Alcohol Dependent users – Advice to stop use and motivate for treatment using Brief intervention* | 194 | list | 0.820 | • Closer monitoring and nursing care • Treatment of additional psychiatric disorder or substance use disorder TERTIARY CARE • Treatment of delirium tremens • R/ o head injury, hepatic encephalopathy, Wernicke’s encephalopathy • R/ o other causes of delirium • Manage on similar lines as withdrawal seizures • Management in ICU setting when indicated • Consult with other medical specialists (like gastroenterology or medicine for hematemesis). | ||||
| What tests are recommended for patients with significant liver dysfunction during alcohol withdrawal treatment? | CBC Liver function test Blood sugar Electrolytes | • Tab Diazepam (20-40mg/day in divided doses) based on severity of withdrawals. • Monitor and titrate dose. • If patient comfortable, reduce dose of medication by 10% to 20% per day, taper within 7 to 10 days • Thiamine 100 mg OD • Significant liver dysfunction: Lorazepam (2 mg Lorazepam equal to 5 mg Diazepam) CBC Liver function test Blood sugar Electrolytes | 313 | list | 0.820 | • If patient comfortable, reduce dose of medication by 10% to 20% per day, taper within 7 to 10 days • Thiamine 100 mg OD • Significant liver dysfunction: Lorazepam (2 mg Lorazepam equal to 5 mg Diazepam) CBC Liver function test Blood sugar Electrolytes | 1 | page=1,block=30 | 0.700 | valid |
Read straight from the file — download or use the API URL for the full dataset.
| 1 |
| page=1,block=3 |
| 0.700 |
| valid |
| 1 |
| page=1,block=3 |
| 0.700 |
| valid |
| 1 |
| page=1,block=34 |
| 0.700 |
| valid |
| 1 |
| page=1,block=34 |
| 0.700 |
| valid |
| 1 |
| page=1,block=34 |
| 0.700 |
| valid |